Regulus business strategy is focused on creating a limited set of significant alliances with leading pharmaceutical partners and academic labs, where both parties bring expertise to the table, to discover and develop microRNA therapeutics.

Regulus has created leading strategic alliances with pharmaceutical partners that provide preclinical, clinical, and commercial expertise. In addition, Regulus has maintained active external collaborations with leading academic researchers since its inception. The extensive collaborative network with the world’s top laboratories positions Regulus at the leading edge of microRNA science, enabling Regulus to efficiently translate novel discoveries into therapeutic programs.

Regulus is the business leader in microRNA therapeutics